The affinity maturation of antibodies is driven by somatic hypermutati
on which is localized to specific segments of the coding genes. The in
formation available on this process derives from studies in vivo. With
the intention of developing new approaches, we have constructed a fus
ion gene between a kappa chain and a selectable neomycin resistance ge
ne, neo(r). The neo(r) gene, which includes the SV40 small t intron an
d polyadenylation site, but not the upstream elements nor its first 12
amino acids, is an in-frame substitution of the FR2-CDR3 fragment of
a rearranged V kappa Ox1-J kappa 5 gene. Expression of neo(r) activity
is therefore dependent on the upstream immunoglobulin sequence. A sto
p codon was placed in the CDR1 region so that only mutants survive tre
atment with geneticin sulphate (G418). The effectiveness of the system
was tested by transfecting the NS0 myeloma cell line and isolating sp
ontaneous mutants. Neomycin-resistant clones arose at an estimated rat
e of 1 x 10(-8)/cell division, and over 90% were authentic structural
mutants. Unlike the somatic hypermutations, the majority arose by in-f
rame deletions including the stop codon, although up to 30% involved a
point mutation. The reporter gene was then modified by substituting a
ll the sequences downstream of the J kappa 5 with others known to be r
equired for full hypermutation in vivo. Different cell lines were tran
sfected and G418-resistant clones analyzed. No significant increase in
the rate of reversion or in the generation of point mutations versus
deletions was detected, even using conditioned culture medium. In the
presence of azacytidine however, a mutant involving multiple events (s
ingle base addition and deletion plus two point mutations) was detecte
d. The reporter gene system therefore seems suitable to test culture c
onditions and modifications of the host cells aimed at the derivation
of an in vitro assay of somatic hypermutation.